Home
Abeona Therapeutics

Abeona Therapeutics Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainabeonatherapeutics.com

Year Founded1974

Employees51 - 200

Annual Revenue$2M - $5M

Abeona Therapeutics

Abeona Therapeutics (including company regionals)

abeonatherapeutics.com

See more website traffic and engagement information

Abeona Therapeutics Revenue up to November 2025 is 2M - 5M

revenue generated by Abeona Therapeutics top domains

Abeona Therapeutics top domains revenue over 3 years

Revenue for Abeona Therapeutics top domains

abeonatherapeutics.com2M - 5M

See more with Sales Intelligence

Total visits to Abeona Therapeutics's top domains

Understand Abeona Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

abeonatherapeutics.com6.3K

See more with Sales Intelligence

Avg. visit duration in Abeona Therapeutics's top domains

Analyze Abeona Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

abeonatherapeutics.com00:00:33

See more with Sales Intelligence

Avg. pageviews on Abeona Therapeutics's top domains

See how Abeona Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

abeonatherapeutics.com1.94

See more with Sales Intelligence

Abeona Therapeutics top competitors by domain

Top similar sites in November 2025, ranked by their affinity

g1therapeutics.comCompany NameG1 TherapeuticsEmployees51 - 200HQUnited States, North Carolina, DurhamAnnual revenue$50M - $75MTotal visits3.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Abeona Therapeutics

These are the website technologies, by industry, used by Abeona Therapeutics top domains

Email Services (3)

Microsoft Exchange Online

Widget (3)

Twemoji

Mobile (2)

Meta Viewport

Advertising (1)

DoubleClick

More Technologies

8

See all

News & Signals from Abeona Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbeona Therapeutics Inc. launches commercial patient treatment of prademagene zamikeracel.Abeona Therapeutics has announced the first commercial patient treatment of prademagene zamikeracel (Zevaskyn), an FDA-approved therapy for adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB).

NewsAbeona Therapeutics Inc. hired James A. Gow as Senior Vice President, Head of Clinical Development & Medical Affairs on Oct 20th '25.CLEVELAND, Oct. 20, 2025 (GLOBE NEWSWIRE) - Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the appointment of James A. Gow, MD, MBA, MS, MHCM, as the Senior Vice President, Head of Clinical Development & Medical Affairs, effective immediately.

NewsAbeona Therapeutics Inc. launched Qualified Treatment Center on Jul 15th '25.CLEVELAND, July 15, 2025 (GLOBE NEWSWIRE) - Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of the newest Qualified Treatment Center (QTC) for FDA-approved ZEVASKYN (prademagene zamikeracel) gene-modified cellular sheets.